T 0162/22 (Treatment of dIBS with rifaximin/SALIX) of 09.10.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T016222.20241009
- Date of decision
- 9 October 2024
- Case number
- T 0162/22
- Petition for review of
- -
- Application number
- 09715020.5
- IPC class
- A61K 31/437A61P 31/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHODS FOR TREATING IRRITABLE BOWEL SYNDROME
- Applicant name
- Salix Pharmaceuticals, Inc.
- Opponent name
- Sandoz GmbH
Kraus & Lederer PartGmbB
Teva Pharmaceutical Industries Ltd. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.